Quidel Colon Cancer POC Diagnostic Put to the Test
Quidel Corp recently presented data from a correlation study for its QuickVue iFOB (immunochemical Fecal Occult Blood) test for colorectal cancer (CRC) screening.
Read MoreMonth: December 2008
New Diagnostic 98% Accurate Detecting Early Stage Ovarian Cancers
Diagnostics developer HealthLinx Limited has completed an initial Phase II biomarker trial on its ovarian cancer diagnostic that has increased the efficiency of the panel to 98% for early stage diagnosis.
Read MoreBiomarkers Could Aid Diagnosis of Two Fatal Forms of Malaria
Canadian researchers have identified protein biomarkers that shed new light on the development of two severe and debilitating forms of malaria.
Read MoreFDA Teams With WebMD For Online Consumer Health Information
The FDA and WebMD today announced a collaboration that expands consumers’ access to the agency’s timely and reliable important health information.
Read MoreIBT Laboratories Adds Two New Assays for Immune Deficiency
BT Laboratories announces that it has launched two new assays, the T Cell Fx test and the Mannan Binding Lectin (MBL) Pathway Function Test.
Read More